These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
670 related articles for article (PubMed ID: 28650561)
1. Craniosynostosis in patients with RASopathies: Accumulating clinical evidence for expanding the phenotype. Ueda K; Yaoita M; Niihori T; Aoki Y; Okamoto N Am J Med Genet A; 2017 Sep; 173(9):2346-2352. PubMed ID: 28650561 [TBL] [Abstract][Full Text] [Related]
2. Clinical and molecular characterization of children with Noonan syndrome and other RASopathies in Argentina. Chinton J; Huckstadt V; Moresco A; Gravina LP; Obregon MG Arch Argent Pediatr; 2019 Oct; 117(5):330-337. PubMed ID: 31560489 [TBL] [Abstract][Full Text] [Related]
3. Clinical and molecular analysis of RASopathies in a group of Turkish patients. Şimşek-Kiper PÖ; Alanay Y; Gülhan B; Lissewski C; Türkyilmaz D; Alehan D; Cetin M; Utine GE; Zenker M; Boduroğlu K Clin Genet; 2013 Feb; 83(2):181-6. PubMed ID: 22420426 [TBL] [Abstract][Full Text] [Related]
4. Cardiac manifestations and gene mutations of patients with RASopathies in Taiwan. Lee CL; Tan LTH; Lin HY; Hwu WL; Lee NC; Chien YH; Chuang CK; Wu MH; Wang JK; Chu SY; Lin JL; Lo FS; Su PH; Hsu CC; Ko YY; Chen MR; Chiu HC; Lin SP Am J Med Genet A; 2020 Feb; 182(2):357-364. PubMed ID: 31837205 [TBL] [Abstract][Full Text] [Related]
5. [Cardiofaciocutaneous syndrome, a Noonan syndrome related disorder: clinical and molecular findings in 11 patients]. Carcavilla A; García-Miñaúr S; Pérez-Aytés A; Vendrell T; Pinto I; Guillén-Navarro E; González-Meneses A; Aoki Y; Grinberg D; Ezquieta B Med Clin (Barc); 2015 Jan; 144(2):67-72. PubMed ID: 25194980 [TBL] [Abstract][Full Text] [Related]
6. Autism traits in the RASopathies. Adviento B; Corbin IL; Widjaja F; Desachy G; Enrique N; Rosser T; Risi S; Marco EJ; Hendren RL; Bearden CE; Rauen KA; Weiss LA J Med Genet; 2014 Jan; 51(1):10-20. PubMed ID: 24101678 [TBL] [Abstract][Full Text] [Related]
7. Genetic landscape of RASopathies in Chinese: Three decades' experience in Hong Kong. Yu KPT; Luk HM; Leung GKC; Mak CCY; Cheng SSW; Hau EWL; Chan DKH; Lam STS; Tong TMF; Chung BHY; Lo IFM Am J Med Genet C Semin Med Genet; 2019 Jun; 181(2):208-217. PubMed ID: 30896080 [TBL] [Abstract][Full Text] [Related]
8. Objective studies of the face of Noonan, Cardio-facio-cutaneous, and Costello syndromes: A comparison of three disorders of the Ras/MAPK signaling pathway. Allanson JE Am J Med Genet A; 2016 Oct; 170(10):2570-7. PubMed ID: 27155212 [TBL] [Abstract][Full Text] [Related]
9. Epilepsy in RAS/MAPK syndrome: two cases of cardio-facio-cutaneous syndrome with epileptic encephalopathy and a literature review. Adachi M; Abe Y; Aoki Y; Matsubara Y Seizure; 2012 Jan; 21(1):55-60. PubMed ID: 21871821 [TBL] [Abstract][Full Text] [Related]
10. A review of craniofacial and dental findings of the RASopathies. Cao H; Alrejaye N; Klein OD; Goodwin AF; Oberoi S Orthod Craniofac Res; 2017 Jun; 20 Suppl 1(Suppl 1):32-38. PubMed ID: 28643916 [TBL] [Abstract][Full Text] [Related]
11. Familial cardio-facio-cutaneous syndrome: Vertical transmission of the BRAF p.G464R pathogenic variant and review of the literature. Rauen KA; Maeda Y; Egense A; Tidyman WE Am J Med Genet A; 2021 Feb; 185(2):469-475. PubMed ID: 33274568 [TBL] [Abstract][Full Text] [Related]
12. Expanding the clinical phenotype of RASopathies in 38 Turkish patients, including the rare LZTR1, RAF1, RIT1 variants, and large deletion in NF1. Uludağ Alkaya D; Lissewski C; Yeşil G; Zenker M; Tüysüz B Am J Med Genet A; 2021 Dec; 185(12):3623-3633. PubMed ID: 34184824 [TBL] [Abstract][Full Text] [Related]
13. New Mutations Associated with Rasopathies in a Central European Population and Genotype-Phenotype Correlations. Čizmárová M; Hlinková K; Bertok S; Kotnik P; Duba HC; Bertalan R; Poločková K; Košťálová Ľ; Pribilincová Z; Hlavatá A; Kovács L; Ilenčíková D Ann Hum Genet; 2016 Jan; 80(1):50-62. PubMed ID: 26607044 [TBL] [Abstract][Full Text] [Related]
14. Severe craniosynostosis with Noonan syndrome phenotype associated with SHOC2 mutation: clinical evidence of crosslink between FGFR and RAS signaling pathways. Takenouchi T; Sakamoto Y; Miwa T; Torii C; Kosaki R; Kishi K; Takahashi T; Kosaki K Am J Med Genet A; 2014 Nov; 164A(11):2869-72. PubMed ID: 25123707 [TBL] [Abstract][Full Text] [Related]
15. Noonan, Costello and cardio-facio-cutaneous syndromes: dysregulation of the Ras-MAPK pathway. Tidyman WE; Rauen KA Expert Rev Mol Med; 2008 Dec; 10():e37. PubMed ID: 19063751 [TBL] [Abstract][Full Text] [Related]
16. Rasopathies - dysmorphic syndromes with short stature and risk of malignancy. Cizmarova M; Kostalova L; Pribilincova Z; Lasabova Z; Hlavata A; Kovacs L; Ilencikova D Endocr Regul; 2013 Oct; 47(4):217-22. PubMed ID: 24156711 [TBL] [Abstract][Full Text] [Related]
17. Noonan syndrome and clinically related disorders. Tartaglia M; Gelb BD; Zenker M Best Pract Res Clin Endocrinol Metab; 2011 Feb; 25(1):161-79. PubMed ID: 21396583 [TBL] [Abstract][Full Text] [Related]
18. LYMPHODYSPLASIA AND KRAS MUTATION: A CASE REPORT AND LITERATURE REVIEW. Morcaldi G; Bellini T; Rossi C; Maghnie M; Boccardo F; Bonioli E; Bellini C Lymphology; 2015 Sep; 48(3):121-7. PubMed ID: 26939159 [TBL] [Abstract][Full Text] [Related]
19. Neurodevelopmental Aspects of RASopathies. Kim YE; Baek ST Mol Cells; 2019 Jun; 42(6):441-447. PubMed ID: 31250618 [No Abstract] [Full Text] [Related]
20. Alterations in RAS-MAPK genes in 200 Spanish patients with Noonan and other neuro-cardio-facio-cutaneous syndromes. Genotype and cardiopathy. Ezquieta B; Santomé JL; Carcavilla A; Guillén-Navarro E; Pérez-Aytés A; Sánchez del Pozo J; García-Miñaur S; Castillo E; Alonso M; Vendrell T; Santana A; Maroto E; Galbis L Rev Esp Cardiol (Engl Ed); 2012 May; 65(5):447-55. PubMed ID: 22465605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]